Thomas Keesling v. World Class Health, Inc.

Court of Chancery of Delaware·Decided August 14, 2026·No. 2026-0140-LM·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

THOMAS KEESLING, )

)

Plaintiff, )

)

v.

) C.A. No. 2026-0140-LM WORLD CLASS HEALTH, ) INC., a Delaware Corporation, )

)

Defendant. )

Date Submitted: June 10, 2026 Final Report: August 14, 2026

POST-TRIAL FINAL REPORT

Thomas Keesling, Parma, OH; Plaintiff.

Joseph B. Cicero, Dakota B. Eckenrode, CHAPMAN BROWN CICERO & COLE, LLP, Wilmington, DE; Counsel for Defendant.

MITCHELL, M.

I. INTRODUCTION This action arises under 8 Del. C. § 220. Plaintiff Thomas Keesling, a former consultant and current stockholder of Defendant World Class Health, Inc., demanded inspection of books and records to value his equity and to investigate potential mismanagement, wrongdoing, and breaches of fiduciary duty. The Company declined the demands, asserting that a provision in Keesling’s Stock Option Agreement waived statutory inspection rights, that Keesling lacked a proper purpose, and that the demands exceeded the scope of Section 220. As such, this action required the Court to determine whether the Option Agreement effected a waiver of Plaintiff’s statutory inspection rights, whether the demand satisfied § 220’s procedural requirements, whether Plaintiff established a proper purpose, and, if so, the necessary and essential scope of inspection under the statute.

As further explained herein, the Court finds that the Option Agreement’s waiver did not bar Plaintiff’s statutory inspection rights. Only Plaintiff’s November 26, 2025, demand, however, satisfied Section 220’s procedural requirements. Plaintiff established proper purposes to value his shares and investigate potential corporate mismanagement, but his inspection is limited to records that are necessary and essential to accomplish those purposes, not the broader categories of documents he requested. Accordingly, Plaintiff’s demand is GRANTED in part and DENIED in part. This is my Final Report.

II. FACTUAL BACKGROUND 1 A. The Parties Defendant WCH (“WCH” or the “Company”) is a Delaware corporation operating in the healthcare industry whose sole director is Siddharth “Sid” Nambiar.2 At all relevant times, Siddharth Nambiar served as WCH’s Chief Executive Officer, and acted on the Company’s behalf in its dealings with Thomas Keesling (the “Plaintiff” or “Keesling”). 3 Keesling, a longtime healthcare executive, co-founded IndusHealth, Inc. (“IndusHealth”), with Rajesh Rao.4 Through his work with IndusHealth, Keesling developed a business relationship with WCH, which ultimately evolved into an ongoing consulting arrangement and, later, Keesling’s ownership interest in WCH. 5

1 The facts in this Report reflect my findings based on the record developed at the half- day trial held on June 10, 2026. I grant the evidence the weight and credibility I find it deserves. Citations to the Docket are cited in the form of “D.I. __.” Citations to the transcript are in the form of “Tr. __.” The parties submitted joint exhibits numbered 1–32. Citations to the joint exhibits are in the form of “JX__.” 2 D.I. 1 at 7; D.I. 34 at 10; D.I. 36 at 2.

3 D.I. 1 at 4; D.I. 34 at 14.

4 D.I. 1 at 12.

5 D.I. 1 at 10; D.I. 34 at 33; D.I. 36 at 5.

B. IndusHealth Transaction On May 14, 2024, WCH and IndusHealth executed a term sheet (“Term Sheet”) contemplating WCH’s acquisition of IndusHealth.6 The Term Sheet contemplated that the parties would negotiate and execute definitive transaction documents, and expressly provided that, except for certain enumerated provisions, binding obligations would arise only upon the execution of those definitive agreements. 7 Consistent with the Term Sheet, WCH executed documents that were required to complete the transaction, including an Employment Agreement (“Employment Agreement”), and Independent Contractor Agreement (“Independent Contractor Agreement”) between the Company and Keesling on May 14, 2024.8 Under the Independent Contractor Agreement, Keesling agreed to provide consulting services to WCH, and would have been eligible to receive options to purchase WCH common stock, subject to approval by WCH’s Board of Directors.9

6 D.I. 36 at 2.

7 See JX-1 at 3 (“Legally binding obligations between the parties will be created only through execution and delivery of definitive documents.”). 8 D.I. 36 at 3–4.

9 Id. at 3.

C. Execution of the Equity Plan Option Agreement & Waiver On April 16, 2025, nearly one year after the parties executed the Term Sheet, WCH delivered to Keesling the Equity Incentive Plan Option Agreement (“Option Agreement” or “Agreement”) under the Company’s 2024 Equity Incentive Plan.10 The Agreement granted Keesling the option to purchase vested shares of WCH shares and included Section 15 titled “Waiver of Statutory Information Rights.”11 The parties dispute the legal effect of that provision, which lies at the center of this Action.

On April 17, 2025, one day after receiving and executing the Option Agreement, Keesling submitted a request to exercise 5,000 vested stock options.12 WCH did not immediately approve the exercise because it was evaluating its potential legal remedies related to Plaintiff’s failure to comply with his obligations under the Term Sheet. 13 Eventually, on September 30, 2025, WCH’s Board authorized Keesling’s exercise request and approved the issuance of 5,000 shares of WCH common stock.14 From that point forward, Keesling became a stockholder of WCH.

10 Id. at 4.

11 Id. at 4–5, 15.

12 D.I. 34 at 14; D.I. 36 at 5.

13 D.I. 36 at 5.

14 Id.

D. Plaintiff’s Section 220 Demands The parties’ relationship deteriorated during 2025 as disagreements emerged concerning the status of the IndusHealth transaction and WCH’s alleged use of IndusHealth’s business information. Keesling believed WCH had used IndusHealth’s operating history and performance metrics in connection with its November 2024 and April 2025 financing rounds, which together raised approximately $18 million, despite never completing the acquisition contemplated by the May 2024 Term Sheet.15 According to Keesling, WCH never produced the definitive transaction documents referenced in the Term Sheet.16 Those concerns prompted Keesling to seek inspection of WCH’s books and records.

On March 21, 2025, Keesling served his first demand seeking to inspect WCH’s books and records.17 He followed with a second written demand on April 4, 2025, again requesting inspection after receiving no substantive response to his initial demand. 18 On October 20, 2025, Keesling served a third inspection demand requesting, among other things, that WCH cease using IndusHealth’s proprietary

15 D.I. 34 at 12, 19.

16 Id. at 20.

17 JX-4; D.I. 36 at 4.

18 JX-6; D.I. 34 at 16; D.I. 36 at 4.

information and correct what he characterized as misrepresentations concerning the parties’ Term Sheet. 19 WCH responded to the demands by disputing both the sufficiency of Keesling’s inspection demand and the merits of the allegations contained in his October 20, 2025 letter, characterizing those allegations as “unfounded” and “legally insufficient.” 20 The Company advised that, if Keesling initiated litigation on those grounds, it would “vigorously defend itself” and anticipated litigation costs exceeding more than $300,000.21 At the same time, WCH offered to purchase Keesling’s entire equity interest for $200,000, subject to a mutual release of claims, stating that the offer would remain open until November 5, 2025. 22 On November 10, 2025, WCH terminated Keesling’s consulting Independent Contractor Agreement. 23 Keesling contends that the termination did not comply with Section 10.2 of the Independent Contractor Agreement. 24 On November 26, 2025, Keesling served his fourth and final demand (“November Demand”). 25 The demand sought inspection of numerous categories of

19 See JX-11.

20 See JX-12.

21 Id.

22 Id.

23 See JX-13.

24 D.I. 34 at 17 25 See JX-14.

Free access — add to your briefcase to read the full text and ask questions with AI

Thomas Keesling v. World Class Health, Inc., (Del. Ct. App. 2026).

Thomas Keesling v. World Class Health, Inc. (Thomas Keesling v. World Class Health, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Minna v. Energy Coal S.P.A.
984 A.2d 1210 (Supreme Court of Delaware, 2009)
Seinfeld v. Verizon Communications, Inc.
909 A.2d 117 (Supreme Court of Delaware, 2006)
Abry Partners V, L.P. v. F & W Acquisition LLC
891 A.2d 1032 (Court of Chancery of Delaware, 2006)
Kortüm v. Webasto Sunroofs, Inc.
769 A.2d 113 (Court of Chancery of Delaware, 2000)
Bantum v. New Castle County Vo-Tech Education Ass'n
21 A.3d 44 (Supreme Court of Delaware, 2011)